Sign in

CIK 0000906709

  • Non-accelerated filer
  • Smaller reporting company

NEKTAR THERAPEUTICS

Sign in to watch
Ticker
NKTR
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
943134940
Phone
+1 415-482-5300
Business address
455 MISSION BAY BOULEVARD SOUTH, SAN FRANCISCO, CA, 94158
Former names
INHALE THERAPEUTIC SYSTEMS INC, INHALE THERAPEUTIC SYSTEMS
  1. 4 Open-market sale President & CEO sold 91,714 shares at an average $19.26 ($1,766,081)
  2. 4 Open-market sale SVP & Chief Operating Officer sold 3,177 shares at $19.32 ($61,380)
  3. 4 Open-market sale SVP & Chief Financial Officer sold 3,177 shares at $19.32 ($61,380)
  4. 4 Open-market sale SVP Pharma Dev & Mfg Ops sold 2,956 shares at $19.32 ($57,110)
  5. 4 Open-market sale SVP & Chief Medical Officer sold 1,997 shares at $19.32 ($38,582)
  6. 4 Open-market sale SVP & Chief Scientific Officer sold 1,701 shares at $19.32 ($32,863)
  7. 4 Open-market buy Director bought 35,000 shares at $17.95 ($628,250)
  8. 4 Open-market sale SVP & Chief Medical Officer sold 54,920 shares at $21.10 ($1,158,812)
  9. 4 Open-market sale Director sold 30,000 shares at $20.76 ($622,800)
  10. 4 Open-market sale SVP & Chief Medical Officer sold 45,080 shares at an average $21.08 ($950,318)
  11. 4 Exercise or conversion Director acquired 15,000 shares (option exercise)
  12. 4 Open-market sale SVP & Chief Operating Officer sold 101,700 shares at $19.24 ($1,956,708)
  13. 4 Open-market sale SVP & Chief Accounting Officer sold 2,651 shares at $19.55 ($51,827)
  14. 4 Open-market sale President & CEO sold 8,388 shares at $19.55 ($163,985)
  15. 4 Open-market sale SVP & Chief Operating Officer sold 3,146 shares at $19.55 ($61,504)
  16. 4 Open-market sale SVP & Chief Financial Officer sold 3,179 shares at $19.55 ($62,149)
  17. 4 Open-market sale SVP Pharma Dev & Mfg Ops sold 2,959 shares at $19.55 ($57,848)
  18. 4 Open-market sale SVP & Chief Medical Officer sold 1,450 shares at $19.55 ($28,348)
  19. 4 Open-market sale SVP & Chief Scientific Officer sold 1,701 shares at $19.55 ($33,255)
  20. 4 Open-market sale Director sold 5,000 shares at $19.79 ($98,950)

Page 21 of 49 · 970 filings